Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
1.
Life Sci ; 312: 121213, 2023 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-36423671

RESUMEN

AIMS: The objective of this study is to provide a reliable strategy for the diagnosis of sarcopenia based on a complementary combination of biomarkers from various approaches. MATERIAL AND METHODS: A total of 30 C57BL/6J mice were used for the experiment, in which 15 young mice (YM) at 24 weeks old and 15 aged mice (AM) at 88 weeks old. Extracted features-based digital biomarkers from the electromyography activity of tibialis anterior muscles were evaluated by using receiver operating characteristic analysis. Extracted tissular proteins and circulating hormones based chemical biomarkers were investigated by using immunoblotting and enzyme-linked immunosorbent assay. KEY FINDINGS: In terms of digital biomarkers, the feature-based classification of mice groups showed good performance (Feature A: AUC = 0.986, accuracy = 0.928) and (Feature B: AUC = 0.999, accuracy = 0.990). On the other hand, muscle-specific protein levels based chemical biomarkers (e.g. MuRF1, FoxO1, and perilipin2) were observed significantly increase with age. Pro-inflammatory cytokines based biomarkers extracted from muscle tissue and circulating plasma (e.g. TNF-α, IL-6, and IL-8) were significantly higher in case of AM group compared to YM group. Circulating hormone-based chemical biomarkers (e.g. cortisol/DHEA ratio and cathepsin D) presented a significant increase in concentrations with age. Circulating neurotransmitter based biomarkers (e.g. acetylcholine, serotonin, and histamine) also increased significantly in concentrations from YM to AM. SIGNIFICANCE: A complementary combination of digital and chemical biomarkers covers multiple domains of sarcopenia to provide an effective strategy for the early diagnosis of sarcopenia.


Asunto(s)
Sarcopenia , Ratones , Animales , Sarcopenia/diagnóstico , Ratones Endogámicos C57BL , Biomarcadores , Músculo Esquelético/fisiología , Factor de Necrosis Tumoral alfa
2.
Biomed Pharmacother ; 103: 524-530, 2018 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-29677538

RESUMEN

BACKGROUND: Menopausal hot flushes occur frequently in postmenopausal women. In the present study, we investigated a regulatory effect of a mixed extract of flowers of Pueraria thomsonii Benth. and peels of Citrus unshiu Markovich (PCE17), an extract of flowers of Pueraria thomsonii Benth. (PE), an extract of peels of Citrus unshiu Markovich (CE), a mixture of tectorigenin 7-O-xylosylglucoside, tectoridin, and tectorigenin (Tec, the active compounds of PE), and hesperidin (Hes, an active compound of CE) on menopausal hot flushes. METHODS: We examined the anti-hot flushes properties of PCE17, PE, CE, Tec, or Hes using a mouse model of ovariectomy-induced hot flushes. RESULTS: The ovariectomy-induced rise in the tail skin temperature was significantly prevented by PCE17, PE, CE, Tec, or Hes. PCE17, PE, CE, Tec, or Hes significantly enhanced 5-HT levels and attenuated RANKL levels in the hypothalamus of ovariectomized (OVX) mice. Treatment with PCE17, PE, CE, Tec, or Hes significantly enhanced the levels of estrogen receptor (ER)-ß, 5-HT1A, 5-HT2A, and tryptophan hydroxylase mRNA expression in the hypothalamus of OVX mice. PCE17, PE, or CE decreased follicle-stimulating hormone (FSH) and luteinizing hormone (LH) levels, but did not increase estrogen levels in the serum of OVX mice. Tec or Hes decreased FSH or LH levels and increased estrogen levels. Treatment with PCE17, PE, CE, or Tec ameliorated vaginal atrophy in OVX mice. Finally, PCE17, PE, CE, Tec, or Hes significantly increased norepinephrine and dopamine levels in the hypothalamus of OVX mice. CONCLUSION: Thus, these results imply that PCE17 has protective effects against hot flushes.


Asunto(s)
Citrus , Flores , Ovariectomía/efectos adversos , Extractos Vegetales/administración & dosificación , Posmenopausia/efectos de los fármacos , Pueraria , Animales , Quimioterapia Combinada , Femenino , Sofocos/tratamiento farmacológico , Sofocos/patología , Ratones , Ratones Endogámicos BALB C , Fitoterapia/métodos , Extractos Vegetales/aislamiento & purificación , Posmenopausia/fisiología , Resultado del Tratamiento , Vagina/efectos de los fármacos , Vagina/patología
3.
Chin J Nat Med ; 16(2): 97-104, 2018 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-29455734

RESUMEN

Bamboo salt (BS) is a traditional Korean food, and has been reported to have anti-cancer, anti-inflammatory, and anti-metastatic effects. However, the anti-atopic dermatitis (AD) activity of BS has not been described yet. In the present study, we examined the preventive effect of BS on AD. The effect of oral administration of BS was tested in a 2, 4-dinitrofluorobenzene (DNFB)-induced AD animal model, by histological analysis, enzyme-linked immunosorbent assay, reverse transcription-polymerase chain reaction, caspase-1 assay, and Western blotting analysis. BS administration reduced the total clinical severity and scratching frequencies, compared with the AD group. In the serum of DNFB-induced AD mice, the levels of IgE, histamine, thymic stromal lymphopoietin (TSLP), interleukin (IL)-5, and IL-13 were significantly reduced by BS treatment. BS significantly reduced the protein and mRNA expression of TSLP, IL-6, and tumor necrosis factor-α in the AD skin lesions. BS markedly reduced the infiltration of inflammatory cells. Furthermore, the activation of caspase-1 was reduced by BS in the AD skin lesions. Our results suggested that BS should be considered as a candidate treatment for allergic inflammatory diseases including AD.


Asunto(s)
Dermatitis Atópica/tratamiento farmacológico , Dermatitis Atópica/inmunología , Cloruro de Sodio Dietético/administración & dosificación , Animales , Caspasa 1/genética , Caspasa 1/inmunología , Dermatitis Atópica/inducido químicamente , Dermatitis Atópica/genética , Dinitrofluorobenceno/efectos adversos , Modelos Animales de Enfermedad , Femenino , Histamina/inmunología , Humanos , Inmunoglobulina E/inmunología , Interleucina-13/genética , Interleucina-13/inmunología , Interleucina-5/genética , Interleucina-5/inmunología , Ratones , Ratones Endogámicos BALB C
4.
Immunopharmacol Immunotoxicol ; 40(1): 52-58, 2018 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-29172841

RESUMEN

OBJECTIVES: Artemisia scoparia Waldst. et Kit. (AS) has been used to treat inflammation, urticaria and hepatitis. However, the scientific studies of AS and its active compound for inflammatory reactions in activated human mast cell line, HMC-1 cells have not yet been elucidated. MATERIALS AND METHODS: Here, we isolated 3,5-dicaffeoyl-epi-quinic acid (DEQA) from AS butanol fraction. The anti-inflammatory effect of AS and its new active compound, DEQA was examined in HMC-1 cells by studying the following markers: phorbol 12-myristate 13-acetate and calcium ionophore A23187 (PMACI)-induced thymic stromal lymphopoietin (TSLP), tumor necrosis factor (TNF)-α, interleukin (IL)-1ß and IL-6 secretion and mRNA expression by ELISA and RT-PCR, respectively. Furthermore, mechanism related to anti-inflammatory was examined by Western blotting. RESULTS: We reported that AS and its new active compound, DEQA significantly reduced TSLP, TNF-α, IL-1ß and IL-6 production levels through the reduction of caspase-1 activity. The mRNA expression of these inflammatory cytokine was also reduced via blocking nuclear factor-κB nuclear translocation by AS and DEQA. In addition, AS significantly reduced phosphorylated-c-Jun N-terminal kinase level and DEQA significantly reduced both phosphorylated-c-Jun N-terminal kinase and -p38 mitogen-activated protein kinase levels. CONCLUSIONS: Therefore, these results indicated that AS and its active compound, DEQA may improve mast cell-mediated inflammatory diseases.


Asunto(s)
Artemisia/química , Mastocitos/metabolismo , Ácido Quínico/análogos & derivados , Ácido Quínico/farmacología , Línea Celular , Citocinas/metabolismo , Humanos , Mastocitos/citología , FN-kappa B/metabolismo , Ácido Quínico/química , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo
5.
Pharm Biol ; 55(1): 1856-1862, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-28614972

RESUMEN

OBJECTIVE: To study the anti-inflammatory properties of OJ. CONTEXT: Ojayeonjonghwan (OJ) is a traditional Korean prescription, which has been widely used for the treatment of prostatitis. However, no scientific study has been performed of the anti-inflammatory effects of OJ. MATERIALS AND METHODS: Peritoneal macrophages were isolated 3-4 days after injecting a C57BL/6J mouse with thioglycollate. They were then treated with OJ water extract (0.01, 0.1, and 1 mg/mL) for 1 h and stimulated with lipopolysaccharide (LPS) for different times. Nitric oxide (NO), inducible nitric oxide synthase (iNOS) and cyclooxygenase (COX)-2, and proinflammatory cytokine levels were determined by NO assay, Western blotting, RT-PCR and ELISA. RESULTS: NO generation and iNOS induction were increased in the LPS-activated mouse peritoneal macrophages. However, NO generation and iNOS induction by LPS were suppressed by treatment with OJ for the first time. The IC50 value of OJ with respect to NO production was 0.09 mg/mL. OJ did not influence LPS-stimulated COX-2 induction, but did significantly decrease LPS-stimulated secretions and mRNA expressions of tumour necrosis factor (TNF)-α, interleukin (IL)-6, and IL-1ß. Inhibition rates of TNF-α, IL-6, and IL-1ß at an OJ concentration of 1 mg/mL were 77%, 88%, and 50%, respectively. OJ also suppressed the LPS-induced nuclear translocation of NF-κB. High-performance liquid chromatography showed schizandrin and gomisin A are major components of OJ. CONCLUSIONS: OJ reduces inflammatory response, and this probably explains its positive impact on the prostatitis associated inflammation.


Asunto(s)
Antiinflamatorios no Esteroideos/farmacología , Ciclooctanos/farmacología , Dioxoles/farmacología , Regulación de la Expresión Génica/efectos de los fármacos , Lignanos/farmacología , Activación de Macrófagos/efectos de los fármacos , Macrófagos Peritoneales/efectos de los fármacos , Extractos Vegetales/farmacología , Compuestos Policíclicos/farmacología , Animales , Antiinflamatorios no Esteroideos/análisis , Antiinflamatorios no Esteroideos/química , Células Cultivadas , Ciclooctanos/análisis , Ciclooxigenasa 2/genética , Ciclooxigenasa 2/metabolismo , Citocinas/genética , Citocinas/metabolismo , Dioxoles/análisis , Etnofarmacología , Lignanos/análisis , Lipopolisacáridos/toxicidad , Macrófagos Peritoneales/citología , Macrófagos Peritoneales/inmunología , Macrófagos Peritoneales/metabolismo , Masculino , Medicina Tradicional Coreana , Ratones Endogámicos C57BL , Óxido Nítrico/metabolismo , Óxido Nítrico Sintasa de Tipo II/química , Óxido Nítrico Sintasa de Tipo II/genética , Óxido Nítrico Sintasa de Tipo II/metabolismo , Extractos Vegetales/química , Compuestos Policíclicos/análisis , Prostatitis/tratamiento farmacológico , Prostatitis/inmunología , Prostatitis/metabolismo , Prostatitis/patología , Tioglicolatos
6.
Food Chem Toxicol ; 106(Pt A): 78-85, 2017 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-28545868

RESUMEN

Atractylenolide III (ATL-III) is an active compound of Atractylodes lancea, which has been widely used for the treatment of cancer. Cancer is closely connected with inflammation, and many anti-inflammatory agents are also used to treat cancer. We investigated the influence of ATL-III on thymic stromal lymphopoietin (TSLP)-induced inflammatory reactions. Pretreatment with ATL-III suppressed murine double minute 2 levels and promoted p53 levels in TSLP-treated human mast cell, HMC-1 cells. Mast cell proliferation increased by TSLP or IL-3 stimulation was significantly decreased by ATL-III pretreatment. Interleukin (IL)-13 and phosphorylated signal transducer and activator of transcription 3, 5, and 6 levels in TSLP-treated HMC-1 cells were also decreased by ATL-III pretreatment. In addition, ATL-III decreased the TSLP-induced production of proinflammatory cytokines (IL-6, IL-1ß, tumor necrosis factor-α, and IL-8). ATL-III decreased the levels of Bcl2 and procaspase-3 and increased caspase-3 activation and cleaved PARP levels. Furthermore, ATL-III decreased TSLP-induced mast cell proliferation and the production of inflammatory cytokine by LAD2 cells. Taken together, these findings suggest that ATL-III plays a useful role as an anti-inflammatory agent and should be viewed as a potential anti-cancer agent.


Asunto(s)
Atractylodes/química , Proliferación Celular/efectos de los fármacos , Citocinas/farmacología , Lactonas/farmacología , Mastocitos/citología , Extractos Vegetales/farmacología , Sesquiterpenos/farmacología , Antiinflamatorios/farmacología , Caspasa 3/genética , Caspasa 3/metabolismo , Línea Celular , Humanos , Interleucina-13/genética , Interleucina-13/metabolismo , Mastocitos/efectos de los fármacos , Mastocitos/metabolismo , Fosforilación , Proteínas Proto-Oncogénicas c-mdm2/genética , Proteínas Proto-Oncogénicas c-mdm2/metabolismo , Factor de Transcripción STAT6/genética , Factor de Transcripción STAT6/metabolismo , Linfopoyetina del Estroma Tímico
7.
Mol Immunol ; 78: 121-132, 2016 10.
Artículo en Inglés | MEDLINE | ID: mdl-27636508

RESUMEN

KMP6 (Pyeongwee-San) is a Korean Medicine used to treat gastrointestinal disorders. Recently, we reported KMP6 had beneficial effects on allergic inflammatory diseases. The aim of this study was to evaluate the effects of atractylone (Atr), a constituent of KMP6, on allergic rhinitis (AR) and to identify the mechanism responsible for these effects. The anti-allergic inflammatory effects of Atr were evaluated on phorbol 12-myristate 13-acetate and calcium ionophore A23187 (PMACI)-stimulated human mast cell line, HMC-1 cells and in an ovalbumin (OVA)-induced AR animal model using Western blotting, quantitative real-time PCR, ELISA, and immunohistochemistry methods. In HMC-1 cells, Atr and KMP6 attenuated PMACI-caused proinflammatory cytokine production and mRNA expression. We found that PMACI induced caspase-1/nuclear factor (NF)-κB/mitogen activated protein kinases (MAPKs) activation. PMACI-caused caspase-1/NF-κB/MAPKs activations were attenuated by Atr and KMP6. In AR animal model, Atr and KMP6 reduced AR clinical symptoms and biomarkers including rub scores, total IgE, histamine, prostaglandin D2, thymic stromal lymphopoietin, interleukin (IL)-1ß, IL-4, IL-5, IL-6, IL-13, tumor necrosis factor-α, cyclooxygenase-2, intercellular adhesion molecule-1, and macrophage inflammatory protein-2. In addition, Atr and KMP6 attenuated eosinophils and mast cells invasions into nasal mucosa tissues and diminished mast cell-derived caspase-1 activation. These results indicate that Atr is an active constituent of KMP6 and a potential therapeutic agent for AR.


Asunto(s)
Mastocitos/efectos de los fármacos , Rinitis Alérgica/inmunología , Sesquiterpenos/farmacología , Animales , Western Blotting , Células Cultivadas , Cromatografía Liquida , Modelos Animales de Enfermedad , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Inmunohistoquímica , Inflamación/inmunología , Ratones , Ratones Endogámicos BALB C , Mucosa Nasal/efectos de los fármacos , Extractos Vegetales/farmacología , Reacción en Cadena en Tiempo Real de la Polimerasa , Espectrometría de Masas en Tándem
8.
Int Arch Allergy Immunol ; 167(4): 242-9, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26418257

RESUMEN

BACKGROUND: Anaphylaxis is associated with systemic vasodilation that causes low blood pressure and induces hypoxic brain damage. The sound of a Buk (Korean traditional drum) is similar to the human heart beat and affects blood pressure, heart rate, and the nervous system by increasing physiological excitation and sympathetic nervous system activity. So, this study focused on the effect of Buk music as a means of treating anaphylaxis. METHODS: Mice were given an intraperitoneal injection of compound 48/80 (6.5 mg/kg, a mast cell degranulator). After compound 48/80 injection, mice were exposed to Buk music and white noise for 5 min in a sound isolation booth. The mortality rate was checked over the next 40 min. Levels of hypoxia-inducible factor-1α (HIF-1α) and vascular endothelial growth factor (VEGF) in the serum and brain tissues were analyzed by Western blotting, quantitative real-time PCR, and ELISA methods. RESULTS: Exposure to Buk music significantly reduced compound 48/80-induced mortality and histamine release, as well as HIF-1α and VEGF levels compared with the compound 48/80 group or compound 48/80 and white noise group. Buk music also reduced levels of tumor necrosis factor-α, and significantly increased estrogen receptor-ß mRNA levels. CONCLUSION: These results indicate that Buk music has potential for the treatment of anaphylaxis.


Asunto(s)
Anafilaxia/metabolismo , Anafilaxia/terapia , Receptor beta de Estrógeno/metabolismo , Musicoterapia/métodos , Anafilaxia/genética , Animales , Encéfalo/metabolismo , Citocinas/metabolismo , Modelos Animales de Enfermedad , Receptor beta de Estrógeno/genética , Liberación de Histamina , Humanos , Subunidad alfa del Factor 1 Inducible por Hipoxia/metabolismo , Interleucina-1beta/metabolismo , Masculino , Ratones , Ratones Endogámicos ICR , Música , ARN Mensajero/genética , ARN Mensajero/metabolismo , República de Corea , Factor de Necrosis Tumoral alfa/metabolismo , Factor A de Crecimiento Endotelial Vascular/sangre , Factor A de Crecimiento Endotelial Vascular/metabolismo , p-Metoxi-N-metilfenetilamina/toxicidad
9.
Am J Rhinol Allergy ; 29(3): e87-94, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25975244

RESUMEN

BACKGROUND: Allergic rhinitis (AR) is an allergic inflammatory disease induced by various mediators released by infiltrating inflammatory cells. Vascular endothelial growth factor (VEGF) increases the airway inflammatory response by promoting vascular permeability. Furthermore, it is known that Allium hookeri and one of its constituent compounds, rutin (RU), have anti-inflammatory, antioxidant, and antiplatelet effects. OBJECTIVE: The aim of this study was to evaluate the regulation of AR by RU and A. hookeri. METHODS: We assessed the therapeutic effects and the regulatory mechanisms of A. hookeri and RU on phorbol 12-myristate 13-acetate plus A23187 (PMACI) stimulated human mast cell line (HMC) 1 cells, and ovalbumin (OVA) sensitized mouse model of AR. RESULTS: A. hookeri and RU significantly inhibited the production and messenger RNA (mRNA) expression of VEGF in PMACI-stimulated HMC-1 cells and significantly decreased VEGF levels in our murine AR model. The increased rubs scores and immunoglobulin E and interleukin (IL) 4 levels in OVA-sensitized mice were significantly reduced by the administration of A. hookeri, and RU significantly inhibited the production and mRNA expression and RU. Also, A. hookeri and RU significantly reduced IL-4 and IL-5 production in OVA-stimulated splenocytes. Furthermore, A. hookeri and RU significantly decreased chemokine levels (intercellular adhesion molecule-1, macrophage inflammatory protein-2) in nasal mucosa tissues. In the mouse AR model, A. hookeri and RU significantly prevented eosinophil and mast cell infiltration and reduced inflammatory cytokine levels induced by OVA sensitization. In addition, A. hookeri and RU significantly reduced mast cell-derived caspase-1 activity in OVA-sensitized mice. CONCLUSION: The present study showed that A. hookeri or RU had an anti-allergic inflammatory effects. Analysis of these results indicated that A. hookeri and RU might protect against AR.


Asunto(s)
Cebollas , Fitoterapia , Rinitis Alérgica/tratamiento farmacológico , Rinitis Alérgica/fisiopatología , Rutina/uso terapéutico , Factor A de Crecimiento Endotelial Vascular/fisiología , Animales , Caspasa 1/metabolismo , Línea Celular , Quimiocina CXCL2/metabolismo , Femenino , Inmunohistoquímica , Molécula 1 de Adhesión Intercelular/metabolismo , Mastocitos , Ratones Endogámicos BALB C , Mucosa Nasal/química , Factor A de Crecimiento Endotelial Vascular/sangre
10.
Biofactors ; 41(3): 190-7, 2015 May 06.
Artículo en Inglés | MEDLINE | ID: mdl-25963419

RESUMEN

Oysters (Oys) contain various beneficial components, such as, antioxidants and amino acids. However, the effects of Oys or taurine (Tau), a major amino acid in Oys on bone growth have not been determined. In the present study, we evaluated the effects of Oys or Tau on linear bone growth in a mouse model of protein malnutrition. To make the protein malnutrition in a mouse, we used a low protein diet. Growth plate thickness was increased by Oys or Tau. Bone volume/tissue volume, trabecular thickness, trabecular number, connection density, and total porosity were also improved by Oys or Tau. Oys or Tau increased insulin-like growth factor-1 (IGF-1) levels in serum, liver, and tibia-growth plate. Phosphorylations of Janus kinase 2 (JAK2) and signal transducer and activator of transcription 5 (STAT5) were increased by Oys and by Tau. These findings show that Oys or Tau may increase growth plate thickness by elevating IGF-1 levels and by promoting the phosphorylations of JAK2-STAT5, and suggest that Oys or Tau are growth-promoting substances of potential use in the food and pharmaceutical industries.


Asunto(s)
Desarrollo Óseo/efectos de los fármacos , Huesos/efectos de los fármacos , Dieta con Restricción de Proteínas/efectos adversos , Suplementos Dietéticos , Desnutrición/dietoterapia , Taurina/administración & dosificación , Animales , Densidad Ósea/efectos de los fármacos , Densidad Ósea/genética , Desarrollo Óseo/genética , Huesos/metabolismo , Modelos Animales de Enfermedad , Regulación de la Expresión Génica , Factor I del Crecimiento Similar a la Insulina/agonistas , Factor I del Crecimiento Similar a la Insulina/genética , Factor I del Crecimiento Similar a la Insulina/metabolismo , Janus Quinasa 2/genética , Janus Quinasa 2/metabolismo , Masculino , Desnutrición/etiología , Desnutrición/genética , Desnutrición/patología , Ratones , Ratones Endogámicos ICR , Ostreidae/química , Fosforilación , Porosidad/efectos de los fármacos , Factor de Transcripción STAT5/agonistas , Factor de Transcripción STAT5/genética , Factor de Transcripción STAT5/metabolismo , Transducción de Señal
11.
Arch Pharm Res ; 38(6): 1223-31, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25163682

RESUMEN

Stillen has been used to treat patients with gastric mucosal ulcers and has an anti-inflammatory effect. It is well-known that neuro-inflammatory reactions are related to depression. Here we evaluated the antidepressant-like effect of Stillen on mice subjected to the forced swimming test (FST). Stillen and eupatilin (a major component of Stillen) significantly decreased immobility times compared with the FST control group. In the Stillen-administered group, increased levels of 5-hydroxytryptamine (serotonin) and brain-derived neurotrophic factor protein were observed in the hippocampus. Nissl bodies also increased in the hippocampus neuronal cytoplasm of the Stillen-administered group. Stillen decreased levels of interleukin (IL)-1ß, IL-6, and tumor necrosis factor-α (at the mRNA and protein levels) in the hippocampus and serum, compared with the control group. In addition, the mRNA expression of estrogen receptor-ß increased after Stillen administration in the hippocampus. These findings suggest that Stillen should be viewed as a candidate antidepressant.


Asunto(s)
Antidepresivos/farmacología , Extractos Vegetales/farmacología , Animales , Artemisia/química , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Citocinas/metabolismo , Receptor beta de Estrógeno/biosíntesis , Flavonoides/farmacología , Hipocampo/citología , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Interleucina-1beta/metabolismo , Interleucina-6/metabolismo , Masculino , Ratones , Ratones Endogámicos ICR , Actividad Motora/efectos de los fármacos , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Serotonina/metabolismo , Natación/psicología , Factor de Necrosis Tumoral alfa/metabolismo
12.
J Med Food ; 17(9): 939-48, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-25089715

RESUMEN

Previously, we showed the antiallergic effect of bamboo salt (BS) in allergic rhinitis (AR). We also demonstrated that interleukin (IL)-32 is an important mediator of AR. The aim of this study was to evaluate the effect and specific underlying mechanism of BS, NaCl, and the mineral mixture (components of BS other than NaCl, including zinc, magnesium, and potassium, Mix) on IL-32 signaling using the human monocyte cell line, THP-1. Here, we documented for the first time that BS significantly decreased IL-32-induced thymic stromal lymphopoietin protein and mRNA expression in THP-1 cells. BS treatment significantly inhibited IL-32-induced proinflammatory cytokine production including IL-1ß, IL-8, and tumor necrosis factor (TNF)-α by suppressing nuclear factor-κB, p38 mitogen-activated kinase, and caspase-1 pathways. The presence of BS or Mix effectively suppressed IL-32-induced macrophage-like cell differentiation but NaCl exhibited no effect on monocyte-to-macrophage-like cell differentiation. In IL-32-induced macrophages, the production of IL-1ß, IL-6, IL-8, and TNF-α, and expression of inducible nitric oxide synthase and cyclooxygenase-2, induced by lipopolysaccharide was dramatically decreased in a dose-dependent manner after BS treatment. BS also significantly decreased IL-32-induced nitric oxide, IL-8, and TNF-α production. Furthermore, BS inhibited granulocyte-macrophage colony-stimulating factor-induced IL-32 and IL-8 protein and mRNA expression in EOL-1 cells. Taken together, BS suppressed inflammatory activity by inhibiting the IL-32 signaling pathway in AR.


Asunto(s)
Productos Biológicos/farmacología , Inflamación/metabolismo , Interleucinas/metabolismo , Macrófagos/efectos de los fármacos , Minerales/farmacología , Rinitis Alérgica/metabolismo , Sasa , Antiinflamatorios/farmacología , Antiinflamatorios/uso terapéutico , Productos Biológicos/uso terapéutico , Caspasa 1/metabolismo , Diferenciación Celular/efectos de los fármacos , Células Cultivadas , Ciclooxigenasa 2/metabolismo , Citocinas/genética , Citocinas/metabolismo , Humanos , Inflamación/inducido químicamente , Inflamación/tratamiento farmacológico , Interleucinas/genética , Lipopolisacáridos , Macrófagos/metabolismo , Monocitos/efectos de los fármacos , Monocitos/metabolismo , FN-kappa B/metabolismo , Óxido Nítrico/metabolismo , Óxido Nítrico Sintasa de Tipo II/metabolismo , ARN Mensajero/metabolismo , Rinitis Alérgica/tratamiento farmacológico , Transducción de Señal , Cloruro de Sodio/farmacología , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo , Linfopoyetina del Estroma Tímico
13.
Life Sci ; 98(2): 103-12, 2014 Mar 11.
Artículo en Inglés | MEDLINE | ID: mdl-24447626

RESUMEN

AIMS: The (2'S,7'S)-O-(2-methylbutanoyl)-columbianetin (OMC) is a novel secondary metabolite extracted from Corydalis heterocarpa, which has long been used as a folk medicine for various inflammatory diseases in Korea. We examined the effect of OMC on allergic rhinitis (AR). MAIN METHODS: We assessed the therapeutic effects and regulatory mechanisms of OMC on the phorbol 12-myristate 13-acetate plus A23187-stimulated mast cell line, HMC-1 cells and ovalbumin (OVA)-induced AR models. KEY FINDINGS: OMC significantly decreased the releases of histamine and tryptase from stimulated HMC-1 cells. The degranulation process, characterized by morphological extension of the filopodia on the surface and membrane ruffling, was strongly induced in the stimulated-HMC-1 cell, however OMC suppressed the morphological changes in stimulated-HMC-1 cells. OMC reduced the production and mRNA expression of inflammatory cytokines. These inhibitory actions by OMC were dependent on the regulation of mitogen-activated protein kinases, nuclear factor-κB, and caspapase-1 signaling pathways. In the AR animal model, the increased rub scores and AR biomarkers (histamine and IgE) in ovalbumin (OVA)-sensitized mice were significantly reduced by the administration of OMC. Furthermore, eosinophils and mast cell infiltrations in nasal mucosa tissue were also blocked through the regulation of macrophage-inflammatory protein and intercellular adhesion molecule-1 levels. SIGNIFICANCE: OMC showed the possibility to regulate AR in activated mast cells and OVA-induced AR models. Hence, we suggest that OMC is a powerful and feasible new agent to suppress AR.


Asunto(s)
Cumarinas/uso terapéutico , Citocinas/antagonistas & inhibidores , Rinitis Alérgica Perenne/tratamiento farmacológico , Animales , Inhibidores de Caspasas/química , Inhibidores de Caspasas/farmacología , Inhibidores de Caspasas/uso terapéutico , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Cumarinas/química , Cumarinas/farmacología , Citocinas/genética , Modelos Animales de Enfermedad , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Mastocitos/efectos de los fármacos , Ratones , Ratones Endogámicos BALB C , Reacción en Cadena en Tiempo Real de la Polimerasa , Rinitis Alérgica
14.
Am J Chin Med ; 41(6): 1267-82, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24228600

RESUMEN

BiRyuChe-bang (BRC) is a Korean prescription medicine, which has been used to treat allergic rhinitis at Kyung Hee Medical Center. In this work, we investigated the effects of BRC on mast cell-mediated allergic reactions and inflammatory cytokines production, and identified the active component of BRC. Histamine release was measured from rat peritoneal mast cells (RPMCs). Ear swelling and passive cutaneous anaphylaxis (PCA) were examined in mouse models. Phorbol 12-myristate 13-acetate (PMA) plus A23187-induced inflammatory cytokines production was measured using enzyme-linked immunosorbent assay. Reverse transcriptase-polymerase chain reaction was used for the expressions of tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-8. Activation of nuclear factor (NF)-κB was analyzed by Western blotting. BRC significantly inhibited the compound 48/80-induced ear swelling response, histamine release from RPMCs, PCA activated by anti-dinitrophenyl IgE, and PMA plus A23187-induced inflammatory cytokines production (p < 0.05). In addition, BRC dose-dependently inhibited the mRNA expressions of TNF-α, IL-6, and IL-8 as well as the activation of NF-κB in a human mast cell line, HMC-1 cells. BRC inhibited the levels of TNF-α and IL-6 in mice induced with PCA. Several components of BRC, such as 1,8-Cineole, Linalool, Linalyl acetate, α-Pinene, and α-Terpineol, significantly inhibited the release of histamine from RPMCs (p < 0.05). Among these components, Linalyl acetate was the most effective for inhibiting histamine release. These results indicate that BRC has a potential regulatory effect on allergic and inflammatory reactions mediated by mast cells.


Asunto(s)
Citocinas/biosíntesis , Medicamentos Herbarios Chinos/farmacología , Mediadores de Inflamación/metabolismo , Mastocitos/inmunología , Mastocitos/metabolismo , Anafilaxis Cutánea Pasiva/efectos de los fármacos , Animales , Calcimicina/farmacología , Células Cultivadas , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Medicamentos Herbarios Chinos/química , Ensayo de Inmunoadsorción Enzimática , Liberación de Histamina/efectos de los fármacos , Humanos , Masculino , Ratones , Ratones Endogámicos ICR , Monoterpenos/aislamiento & purificación , Monoterpenos/farmacología , FN-kappa B , Peritoneo/citología , Ratas , Ratas Wistar , Acetato de Tetradecanoilforbol/análogos & derivados , Acetato de Tetradecanoilforbol/farmacología
15.
Arthritis Res Ther ; 14(6): R259, 2012 Nov 28.
Artículo en Inglés | MEDLINE | ID: mdl-23190696

RESUMEN

INTRODUCTION: Interleukin (IL)-32 is an inflammatory cytokine induced by Mycobacterium tuberculosis and Mycobacterium bovis in a variety of cell types and discovered in the synovial of patients with rheumatoid arthritis (RA). Thymic stromal lymphopoietin (TSLP) play several roles in the pathogenesis of RA. However, the role of IL-32 and TSLP in RA has not been elucidated. METHODS: We evaluated the specific mechanism of between IL-32 and TSLP in RA using human monocyte cell line, THP-1 cells. RESULTS: Here we documented for the first time that IL-32 highly increased TSLP production in THP-1 cells and human blood monocytes. TSLP expression was induced by IL-32 via activation of caspase-1 and nuclear factor-κB. TSLP produced by IL-32 increased differentiation of monocytes but depletion of TSLP prevented differentiation of monocytes into macrophage-like cells. Chondroprotective drugs such as chondroitin sulfate (CS) and the traditional Korean medicine, BaekJeol-Tang (BT) decrease production of TSLP and activation of caspase-1 and nuclear factor-κB. In addition, CS and BT inhibited IL-32-induced monocytes differentiation. CONCLUSIONS: Taken together, IL-32 and TSLP are important cytokines involved in the development of RA. The effects of CS and BT were associated with the downregulation of TSLP and caspase-1 through negative regulation of IL-32 pathways in RA.


Asunto(s)
Caspasa 1/metabolismo , Diferenciación Celular/efectos de los fármacos , Citocinas/metabolismo , Interleucinas/farmacología , Macrófagos/efectos de los fármacos , Western Blotting , Línea Celular Tumoral , Células Cultivadas , Sulfatos de Condroitina/farmacología , Citocinas/genética , Activación Enzimática/efectos de los fármacos , Expresión Génica/efectos de los fármacos , Humanos , Macrófagos/metabolismo , Medicina Tradicional Coreana , Monocitos/efectos de los fármacos , Monocitos/metabolismo , FN-kappa B/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Regulación hacia Arriba/efectos de los fármacos , Linfopoyetina del Estroma Tímico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA